Médecins Sans Frontières (MSF) responds to cholera outbreak following gold discovery in Lomera, South Kivu
In early May, Médecins Sans Frontières (MSF) launched an emergency response to a cholera outbreak in Lomera, South Kivu, Democratic Republic of Congo, where a gold rush and poor sanitation fuelled rapid spread of the disease. Over 8,000 people were vaccinated and more than 600 patients received treatment, as teams worked around the clock to provide care and improve access to clean water.
Until recently, Lomera was a quiet lakeside village, barely known to most residents of South Kivu, DRC. That changed overnight last December when gold was discovered in its hills.
The rush for fortune—intensified by economic insecurity caused by clashes between the M23/AFC armed group, the Congolese army (FARDC), and their Wazalendo militia allies—has turned Lomera into a magnet for thousands of people seeking work and safety.
In less than a year, the population exploded from 1,500 to more than 12,000. The village is now a sprawling chaos of mineshafts and makeshift shelters.
'We live in tough conditions without much space, but we put up with it because we need to earn a living,' says Chiza Blonza, who left his farm in Walungu (some 90 kilometres away) behind to work the mines.
Every day, more people arrive, crowding into already packed shelters—sometimes 20 to a room. It was only a matter of time before disaster struck.
'Everything that could possibly fuel a cholera outbreak is here,' says Mathilde Cilley, MSF medical adviser. 'We're seeing severe overcrowding, barely any clean water, open defecation on the hills, and a total lack of waste management."
Cholera is endemic in this part of DRC, and the lake is contaminated by the bacteria, but an epidemic of this scale is unusual. The first 13 cases in Lomera were reported on 20 April. Within two weeks, that number soared by over 700% to 109 cases—a figure likely underestimated. Today, the town accounts for 95% of cholera cases in the Katana health zone, an area that is home to more than 275,000 people.
MSF launched a rapid emergency response on 9 May. Our teams worked around the clock to contain the epidemic. In just four days, we vaccinated more than 8,000 people—though limited supplies meant only single-dose regimens were administered, instead of the recommended two.
More than 600 people have been treated for cholera at a temporary 20-bed cholera treatment unit we set up, with many arriving in critical condition.
'The vast majority of our patients work in the mines, where they use contaminated lake water to separate gold from the earth, exposing themselves to the bacteria,' says Dr Théophile Amani, an MSF doctor in Lomera. 'Tough manual labour and high levels of alcohol consumption mean many are already dehydrated even prior to getting infected."
After treatment, patients receive hygiene kits—buckets, water purification tablets, and soap—and vital health education from MSF staff on how to prevent future infections.
Bonheur Maganda, originally from Kabamba, is among them. He came to work in the mines to provide for his children and said that many of his colleagues had also fallen ill.
'Without MSF, many of them would have died,' he says. 'The health promotion officer explained the importance of washing my hands with clean water and being careful with food. I will share this advice with others.'
MSF also installed a lakeside water treatment facility and distribution point, delivering around 60,000 litres of clean water daily. One hundred latrines and twenty-five supervised handwashing points were set up across the settlement, including at restaurants and public gathering spots. Contact tracing and preventive treatment for those exposed to cholera have been crucial in containing the spread.
MSF's emergency response will soon be handed over to other partners, but there is an urgent need for long-term solutions to guarantee continued access to clean water.
'Without significant investment in water, sanitation, and hygiene infrastructure, outbreaks like this are likely to persist on a regular basis,' warns Muriel Boursier, MSF's head of mission in Bukavu. 'At present, the nearest well is three kilometres away. International partners and local authorities must step up and implement sustainable solutions.'
Given the constant flux of people moving in and out of the town, further vaccine supplies will also be necessary to protect people.
'South Kivu—and eastern DRC as a whole—are facing major logistical hurdles in getting essential medical supplies, including vaccines, medicines, and equipment, to where they're needed most,' says Boursier.
'While insecurity is a factor, the closure of airports in Bukavu and Goma has had an even greater impact, severely restricting our ability to deliver lifesaving aid,' she says. 'International cuts to humanitarian funding have also limited the availability of medical supplies. We urge governing authorities and international partners to do everything possible to help restore access and support the sanitary response to the wide range of health emergencies impacting the region.'
Responding to cholera outbreaks remains a central priority for MSF in DRC. In 2024 alone, MSF teams treated more than 15,000 cholera cases nationwide, working alongside local health authorities and communities to save lives and stop the spread of disease.
Distributed by APO Group on behalf of Médecins sans frontières (MSF).

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
a day ago
- Zawya
Qatar's health expenditure to surge 14% by 2029
DOHA: Qatar's healthcare industry is poised for rapid expansion, with total health spending projected to grow at a compound annual growth rate (CAGR) of 14 percent by 2029, reaching $11.5bn (QR42bn), according to a recent report by Fitch Solutions. Health experts note that this growth would make Qatar the third-largest healthcare market in the Gulf Cooperation Council (GCC) and the tenth-largest in the Middle East and North Africa (MENA) region. Despite these impressive figures, analysts at Fitch Solutions stress that Qatar's overall market opportunities are challenging compared to other regional players. This is primarily due to the country's small population size and modest short-term economic growth prospects. 'The numbers show a healthy trajectory, but we must be careful not to confuse high growth rates with large-scale opportunity,' said Dr. Lisa Kurian, a Doha-based public health specialist. 'Qatar's small population means we are working with a narrower base, even if spending per capita is among the highest in the region.' Government investment, driven by the National Development Strategy 2024–2030, continues to underpin the growth in public health expenditure. Meanwhile, the private sector is benefiting from strong per capita health spending and ongoing public-private partnerships. 'Qatar has done well to encourage private sector involvement without compromising public oversight,' said Dr. Kurian adding that projects like Surgi Art Hospital are proof that collaboration is driving innovation in patient care. On the other hand, digital transformation is also playing a key role in ensuring efficient healthcare delivery. Government-backed initiatives like the Smart Programme (TASMU) aim to leverage big data, AI, and integrated electronic health records to streamline services and prevent resource bottlenecks. In July 2024, the government signed an agreement with AI firm Lunit to introduce AI-powered breast cancer screening tools across primary health centres—an initiative expected to enhance early detection and reduce long-term costs. 'Investing in AI for diagnostics is not just about innovation—it's about sustainability. Early diagnosis means better outcomes and lower treatment costs, which is critical for long-term health system viability, the medical expert said. She also emphasised that 'Technology cannot replace people. Without well-trained, adequately supported staff, even the most advanced tools will fall short of their potential.' As Qatar positions itself as a leader in high-value healthcare within the region, striking the right balance between innovation, infrastructure, and human capital will be critical. Additionally, researchers highlight that the next phase of development must focus on systemic resilience, ensuring that digital health tools, regulatory frameworks, and a capable workforce work together cohesively to deliver quality care for a changing population. With its strong fiscal position, high per capita income, and strategic vision for healthcare advancement, Qatar is also becoming an increasingly attractive destination for international healthcare companies, investors, and research institutions. © Dar Al Sharq Press, Printing and Distribution. All Rights Reserved. Provided by SyndiGate Media Inc. (

Zawya
2 days ago
- Zawya
World Bank Approves Health Resilience Project to Protect Lives and Strengthen Emergency Response in Mozambique
The World Bank has approved the Mozambique Health Emergency Preparedness, Response and Resilience Project, an initiative to strengthen the health system's ability to deliver essential services consistently and equitably. The project targets underserved and climate-vulnerable areas by investing in human resources, infrastructure, and systems that ensure continuity of care during emergencies. This project is part of a regional p rogram to strengthen health security across Eastern and Southern Africa. Mozambique faces frequent floods, cyclones, disease outbreaks, and other emergencies that disrupt health services and put lives at risk. Many communities lack sufficient and trained health workers, access to essential medicines, and the tools to detect and respond quickly to crises. The project seeks to address these gaps by: Strengthening the health workforce capacity, particularly in high-risk areas, by improving recruitment, training, and retention systems; Improving pharmaceutical supply chains by supporting the regulatory agency in bringing more transparency and speed to procurement processes, lowering and standardizing prices of health commodities to ensure access to medicines, particularly during crises; and Enhancing disease surveillance and laboratory capacity to improve early warning and response systems to quickly detect and respond to health emergencies like cholera outbreaks or heatwaves. The project also supports the development of climate-adaptive infrastructure and emergency preparedness plans, recognizing the growing health risks posed by climate change. ' Mozambique is already experiencing the health impacts of shocks and emergencies,' noted Luc Lecuit, World Bank Acting Division Director in Mozambique. 'The program supports the government's efforts to strengthen core health service delivery by investing in preparedness and resilience, ensuring services remain operational during floods, storms, and epidemics.' Financed through a $201 million grant from the International Development Association (IDA)*, the initiative will be implemented over five years, concluding in September 2030. 'By prioritizing practical investments in the foundational pillars of the health sector, the Government of Mozambique is driving greater efficiency across the system and strengthening its emergency response capacity to protect lives,' said João Pires, World Bank Senior Health Specialist and Task Team Leader. 'These efforts are paving the way for bold reforms to ensure the health system remains resilient and responsive, even under pressure.' In parallel, the World Bank, together with other development partners, is increasing its support to the Mozambique health sector through a $63.7 million top-up to the ongoing District and Community Health Services Revitalization Project. This additional financing—comprising $8.7 million from IDA, $5 million from the Global Financing Facility, and $50 million from a multi-donor trust fund supported by Canada, the United Kingdom, and Ireland—will expand the project's impact across the most vulnerable 63 districts of Mozambique. The operation focuses on improving access to quality primary health care, particularly for women, children, and adolescents, and strengthening service delivery at the district and community levels. Both projects align with the forthcoming Mozambique's Health Sector Strategic Plan (PESS, 2025-2034) (PESS 2020–2024) and the National Adaptation Plan (2023), and complement regional efforts to strengthen health security across Eastern and Southern Africa. Distributed by APO Group on behalf of The World Bank Group.


Zawya
2 days ago
- Zawya
Tanoto Foundation Backs Landmark Research to Unlock the Code of Asian Prevalent Diseases
Understanding Asian Cancers and Diabetes Through an Asian Lens SINGAPORE - Media OutReach Newswire - 27 June 2025 - Tanoto Foundation today announced the funding of two transformative, Singapore-based medical research projects focused on diseases that disproportionately affect Asian populations: prevalent and aggressive cancers, and young-onset Type 2 diabetes. The multi-year initiatives aim to generate data-driven insights that can accelerate diagnosis, improve patient outcomes, and guide public health policy. Despite global strides in medicine, Asia continues to face rising rates of cancer and diabetes – diseases that are biologically and clinically distinct in Asian populations but remain under-researched due to a lack of region-specific data. The two research projects, from National Cancer Centre Singapore and Singapore General Hospital, will focus on filling these gaps through deep genomic studies and innovative risk-prediction models. Imelda Tanoto, Member of the Board of Trustees, Tanoto Foundation said: "Singapore is well-positioned to lead in medical science. It has strong research institutions and a population that reflects the diversity of Asia. By supporting researchers here who are focused on health issues that affect Asians, we hope to help drive discoveries that make a real difference to people's lives — both in Singapore and across the region." Tackling Asian-Prevalent Cancers Led by Dr Jason Chan, Medical Oncologist, National Cancer Centre Singapore, the research will investigate four types of cancers with high prevalence and poor outcomes in Asia: Breast Cancer in Asian Women, marked by earlier onset and biological differences compared to Western populations T/NK-Cell Lymphomas, an aggressive blood cancer dominant in East Asians with limited treatment options Bile Duct Cancer (Cholangiocarcinoma), increasingly linked to environmental exposures specific to Asia Rare Asian Cancers, collectively neglected but accounting for up to 25% of all cases in the region These cancers are devastating but remain poorly understood because most research has focused on Western populations," said Dr Chan. "By decoding their molecular and genomic landscapes in Asian patients, we want to uncover new diagnostic and therapeutic opportunities to benefit patients." A key feature of the project is its open-access commitment: anonymised data will be freely available to the broader research community to accelerate further discovery and collaboration. Unmasking Diabetes Risk in Young Singaporeans The second research project, led by Dr Daphne Gardner, Endocrinologist, Singapore General Hospital, will address the rising incidence of Type 2 diabetes in young adults, particularly prevalent in Singapore, where 1 in 5 young adults have prediabetes or diabetes, despite being of normal weight. Unlike traditional assessments that rely heavily on BMI and family history, this project will develop a next-generation risk prediction tool by incorporating non-traditional indicators such as body fat distribution, continuous glucose monitoring, and health-seeking behaviour. "Many young Asians with diabetes don't fit the usual risk profile. They're lean, active, and often overlooked by current screening models," said Dr Gardner. "We want to change that by identifying new risk signals and developing tools that are tailored to Singapore's population and beyond." Findings from the study aim to inform national diabetes screening guidelines and lead to earlier interventions that can curb long-term complications. Singapore as a Hub for Medical Research Advancement In addition to previously supported research projects, these two initiatives reflect a growing recognition of Singapore's role in advancing precision medicine for Asian populations, driven by strong clinical infrastructure, genomic capabilities, and public-private partnerships. Imelda Tanoto added: "We believe precision health can change how we treat and prevent diseases. We're supporting researchers who are not only breaking new ground, but also making sure their work reaches people and communities across Asia. This is something deeply personal to us — it's about improving lives in a way that's inclusive, meaningful, and lasting." This announcement marks a key milestone in Tanoto Foundation's continuing effort to improve the quality of healthcare and health standards, leading to longer and better healthspans. Hashtag: #TanotoFoundation The issuer is solely responsible for the content of this announcement. About Tanoto Foundation At Tanoto Foundation, we unlock human potential, help communities thrive, and create lasting impact. Founded in 1981 by Sukanto Tanoto and Tinah Bingei Tanoto, we are an independent family foundation that believes in providing every person with the opportunity to realize his or her full potential. To do so, we catalyse systems change in education and healthcare. Our approach is impact-first, collaborative, and evidence-based. We invest for the long term and strive to develop leaders who can drive sustained, positive outcomes. More information is available at Tanoto Foundation